Skip to content

Clinical trials

Phase 1 Hepatitis B trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Phase: Phase 1 Country / region: China Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20184
20193
20202
20211
20232
20241
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status4
Recruiting3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fujian Cosunter Pharmaceutical Co. Ltd3
Assembly Biosciences1
Ausper Biopharma Co., Ltd.1
Beijing 302 Hospital1
Beijing Continent Pharmaceutical Co, Ltd.1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1
Epigenic Therapeutics, Inc1
Hoffmann-La Roche1
Jiyan Liu1
Ningbo No.2 Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B17
Hepatitis B, Chronic6
Carcinoma, Hepatocellular2
Acute-On-Chronic Liver Failure1
Bronchiolitis Obliterans Syndrome1
Hepatic Encephalopathy1
Infections1
Liver Diseases1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.